Could a simple STI test prevent preterm birth?
NCT ID NCT07458802
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study will test whether screening pregnant women for chlamydia and gonorrhea can reduce the risk of preterm birth. About 2,000 women in Botswana will be randomly assigned to receive either standard care or additional STI testing early in pregnancy and again in the third trimester. The goal is to see if finding and treating these infections lowers the number of babies born before 37 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Chlamydia and gonorrhea screening test
- What this could lead to
- If it works, this could lead to a simple, cost-effective way to prevent preterm birth and improve newborn health in high-risk regions.
- What could go wrong
- This is a screening study, not a treatment trial. It may not show a clear benefit, and results may not apply to other populations or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTENATAL CARE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Botswana Harvard Health Partnership
RECRUITINGGaborone, Botswana
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a toddler supplement shape brain power years later?
- Teaching Moms-to-Be about seafood safety: a new weapon against toxic exposures?
- Can Early-Life factors steer preterm and term infant health?
- Immune clues in pregnancy: a new test for preterm birth risk?
- Pocket-sized HIV test could bring same-day diagnosis to community clinics
- A simple survey may curb teen drinking and HIV risk — a trial puts it to the test